AVR 3.48% $10.12 anteris technologies ltd

Ann: Appendix 4C - quarterly, page-66

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,203 Posts.
    lightbulb Created with Sketch. 66
    Wrong. They don't get 'interim' results. They're not allowed to and nor do the docs or participants involved. They might get the results a day or so prior to release, but that's only to tidy them up into presentation form. That is because it would invalidate the study and also be illegal if the direct participants had inside knowledge, so there is an overseeing administration around clinical trials that have some level of inside knowledge, but only really to know if its extreme one way or the other (unsafe or unethical to proceed to completion). If you want to believe that body is so inept or unethical that it would forward information onto a company then you'd be wrong there too. The company will divulge information when it receives it and until then, noone knows what that information will be.
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
(20min delay)
Last
$10.12
Change
0.340(3.48%)
Mkt cap ! $208.0M
Open High Low Value Volume
$9.85 $10.78 $9.65 $107.9K 10.82K

Buyers (Bids)

No. Vol. Price($)
4 657 $10.01
 

Sellers (Offers)

Price($) Vol. No.
$10.16 308 3
View Market Depth
Last trade - 11.34am 19/11/2024 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.